4th Quarter - Report
CELGENE CORPORATION for CELGENE CORPORATION
Firm
Client
Income
—
Expenses
$240,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
H.R. 3757,"Igniting American Research Act",all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALAN EISENBERG New | Congressional Staff, Rep. Greenwood, 2001-2004 |
Health Issues HCR
H.R. 3091,"MODDERN Cures Act of 2013", all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALAN EISENBERG New | Congressional Staff, Rep. Greenwood, 2001-2004 |
| RICHARD T GIRARDS | — |
Copyright/Patent/Trademark CPT
-U.S. policy with respect to China. -U.S. policy with respect to Canada. -U.S. Trans-Atlantic Trade and Investment Partnership. -U.S. Trans-Pacific Partnership.-H.R. 3309, "Innovation Act", issues relating to patent reform. -Trade Promotion Authority.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD T GIRARDS | — |
Medicare/Medicaid MMM
S.1871,"SGR Repeal and Medicare Beneficiary Access Act of 2013", all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALAN EISENBERG New | Congressional Staff, Rep. Greenwood, 2001-2004 |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.